Clinical Trial Update: Temsirolimus in Recurrent Primary Central Nervous System (CNS) Lymphoma [Phase 2]

View source ↗

Summary

This document reports a Phase 2 clinical trial update for temsirolimus in recurrent primary central nervous system lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Drugs mentioned

• Temsirolimus (temsirolimus)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Recurrent or Refractory Primary CNS Lymphoma | Phase 2 | Status: UNKNOWN